Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.
Kinrions
P
P
Department of Clinical Neurological Sciences, Royal College of Surgeons in Ireland, and Beaumont Hospital, Dublin.
Ibrahim
N
N
Murphy
K
K
Lehesjoki
A-E
AE
Järvela
I
I
Delanty
N
N
D000328:Adult; D019943:Amino Acid Substitution; D000927:Anticonvulsants / Q000627:therapeutic use*; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics; D055313:Cystatin B; D015891:Cystatins / Q000235:genetics; D004341:Drug Evaluation; D005260:Female; D006579:Heterozygote; D006801:Humans; D000077287:Levetiracetam; D018598:Minisatellite Repeats; D020125:Mutation, Missense; D020191:Myoclonic Epilepsies, Progressive / Q000188:drug therapy* / Q000235:genetics; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D017354:Point Mutation; D011401:Promoter Regions, Genetic / Q000235:genetics
D000927:Anticonvulsants; C524994:CSTB protein, human; D015891:Cystatins; D000077287:Levetiracetam; D055313:Cystatin B; D010889:Piracetam